SharonAI Holdings earnings beat by $0.03, revenue fell short of estimates

SharonAI Holdings (SHAZ) reported Q3 EPS of $-1.14, beating estimates by $0.03, but revenue of $9.93M missed expectations of $26.94M. The stock is down 66.92% in 3 months but up 721.63% in 12 months. InvestingPro rates its financial health as 'weak performance'.

Original reporting
Published Nov 16, 2026, 9:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 10:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SHAZ
Bearish
medium confidence
Mentioned
$SHAZ
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SHAZBearishMed
01

Why it matters

The key trading signal is the gap between a small EPS beat and a very large revenue miss, which typically drives valuation compression for early-stage or loss-making growth firms.

02

Market read

For SHAZ, the earnings print is likely to dominate near-term positioning because revenue missed consensus by a wide margin.

03

What to watch

The article does not include guidance, cash balance, or segment drivers; traders may need follow-up filings to judge whether the revenue miss is temporary (timing) or structural (demand).

Relevance 7/10Novelty 7/10Timing: after-hours/earnings release timing implied by the published timestamp

Background

The piece summarizes SharonAI Holdings’ Q3 results versus analyst consensus and notes weak financial health.

Company-level read

Ticker impact

$SHAZBearishMedium confidence
Context

SharonAI Holdings reported Q3 EPS of -1.14, slightly above estimates, while revenue missed consensus at $9.93M vs $26.94M.

Expected impact

Likely downward pressure or continued volatility as revenue shortfall outweighs the small EPS beat.

Evidence & confidence

The article provides the company’s own quarterly EPS and revenue versus consensus, with the revenue miss far larger than the EPS beat.

Market effects

Limited spillover; this is a single micro/small-cap earnings print with no sector-wide policy or guidance change described.

Minimal, company-specific impact on US small-cap AI/tech sentiment.

Low, no cross-border deal, regulation, or macro linkage described.

Counterpoint

The EPS beat (less negative than expected) and positive EPS revisions could indicate improving cost structure, which may support a rebound if investors focus on trajectory rather than revenue level.

Key entities

  • SharonAI Holdings

    NASDAQ-listed AI company reporting Q3 EPS and revenue versus consensus.

Related articles

$SHAZMed

What SharonAI (SHAZ) Said on Its Q3 Earnings Call

SharonAI (SHAZ) reported Q3 earnings, highlighting a $1.32B agreement and new contracts totaling $1.17B. The company terminated a $373M contract due to credit risk. CFO Anuj Goel noted $2.6B in capital secured since December 2025, with $1.3B in cash as of Sept. 30. The NVIDIA AICP program covers 72MW and 40,000 GPUs, with billing expected from Q3 2027. SharonAI plans to fund build-out with secured debt and expects $800M in customer deposits.

$SHAZMedAI 8/10

Sharon AI Reports Third Quarter 2026 Results

Sharon AI (SHAZ) reported Q3 2026 results: $9.9M revenue, $43.8M net loss, $1.3B cash. TCV reached $9.6B over 5.5 years. ARR at $50M, expected to hit $400-450M by Jan 2027. Added 80MW capacity, targeting 212MW in 2027. Secured $2.6B in capital since Dec 2025.

$SHAZMedAI 8/10

SharonAI secures $356m GPU-backed debt facility at 9.95%

SharonAI Holdings Inc. (SHAZ) secured a $356M senior secured debt facility at 9.95% to fund GPU deployments. The facility is backed by GPUs and associated cash flows, with proceeds supporting AI infrastructure in the Asia-Pacific region. The company has raised over $2.6B in capital in the past 10 months and has $8.8B in total contract value. Goldman Sachs and private credit funds participated in the facility.